A. Menarini Industrie Farmaceutiche Riunite Srl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:A. Menarini Industrie Farmaceutiche Riunite Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3327
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a several therapeutic and wellness areas including allergy, andrology, antinfective areas, cardiovascular areas, gastrointestinal disorders, gynecology and women’s wellness, respiratory areas, rheumatology, osteoporosis, dermatology and personal care, energy supplements and multivitamins, and others. Menarini operates through its manufacturing sites, research and development centers and has presence across Europe and Asia, Africa, Central and South America. It distributes products across several countries worldwide through partners and distributors. Menarini is headquartered in Florence, Italy.

A. Menarini Industrie Farmaceutiche Riunite Srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 14
Partnerships 15
Melinta Therapeutics Enters into Agreement with Menarini 15
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 16
Menarini Asia-Pacific Enters into Agreement with Merck 17
Menarini Forms Joint Venture with BiosYnth 18
Moberg Extends Distribution Agreement with Menarini for Emtrix 19
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 20
Moberg Pharma Extends Distribution Agreement With Menarini 21
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 22
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 23
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 24
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 25
Licensing Agreements 26
Menarini Enters into Licensing Agreement with Daiichi Sankyo 26
Berlin-Chemie Enters into Licensing Agreement with Selvita 27
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 28
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 29
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 30
Vivus Enters Into Licensing Agreement With Menarini For Spedra 31
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 33
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 34
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 35
FAES Farma Enters into License Agreement with Menarini For Bilastina 36
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 37
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 39
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 40
Acquisition 41
Menarini Group Plans To Acquire Indian Pharma Company 41
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Competitors 42
A. Menarini Industrie Farmaceutiche Riunite Srl – Key Employees 43
A. Menarini Industrie Farmaceutiche Riunite Srl – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 47
Recent Developments 48
Strategy And Business Planning 48
Mar 13, 2017: Menarini Arrives In Columbia And Peru Two New Offices For A Stronger Connection Between Two Continents 48
Jan 18, 2017: Menarini In Turkey: +25% Growth In 2016 And New Headquarters In Istanbul 49
Corporate Communications 50
Jun 29, 2017: Menarini Increases Number of Members of the Board – for the First Time External Members In Majority 50
Product News 51
Apr 12, 2017: Menarini Brings Sirmione Thermal Water Into Italian Homes 51
03/17/2017: Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Key Facts, 2017 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million 14
Melinta Therapeutics Enters into Agreement with Menarini 15
Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite 16
Menarini Asia-Pacific Enters into Agreement with Merck 17
Menarini Forms Joint Venture with BiosYnth 18
Moberg Extends Distribution Agreement with Menarini for Emtrix 19
Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix 20
Moberg Pharma Extends Distribution Agreement With Menarini 21
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 22
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 23
Menarini Enters Into Agreement With Oxford BioTherapeutics To Develop Antibody-Based Anticancer Drugs 24
Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67 25
Menarini Enters into Licensing Agreement with Daiichi Sankyo 26
Berlin-Chemie Enters into Licensing Agreement with Selvita 27
Berlin-Chemie Enters into Licensing Agreement with Chugai Pharma 28
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 29
Menarini Enters into Licensing and Development Agreement with 4SC for Resminostat 30
Vivus Enters Into Licensing Agreement With Menarini For Spedra 31
Furiex Pharma Enters Into Licensing Agreement With Menarini Group For Priligy 33
A. Menarini Industrie Farmaceutiche Riunite Enters into Licensing Agreement with Orion 34
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 35
FAES Farma Enters into License Agreement with Menarini For Bilastina 36
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 37
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 39
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 40
Menarini Group Plans To Acquire Indian Pharma Company 41
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Competitors 42
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Employees 43
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries 44
A. Menarini Industrie Farmaceutiche Riunite Srl, Joint Venture 47

List of Figures
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
A. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
A. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[A. Menarini Industrie Farmaceutiche Riunite Srl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Neptune Technologies & Bioressources Inc:企業のM&A・事業提携・投資動向
    Neptune Technologies & Bioressources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neptune Technologies & Bioressources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Viridian Group Investments Ltd:電力:M&Aディール及び事業提携情報
    Summary Viridian Group Investments Limited (Viridian), a subsidiary of Viridian Group Holdings Limited, is an independent energy company. Through subsidiaries, it generates and supplies electricity in Northern Ireland and the Republic of Ireland (RoI). It supplies natural gas to business customers i …
  • Becton, Dickinson:企業のM&A・事業提携・投資動向
    Becton, Dickinson - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Becton, Dickinson Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Cloverdale Paint Inc:企業の戦略的SWOT分析
    Cloverdale Paint Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Nostra Terra Oil and Gas Company plc (NTOG):企業の財務・戦略的SWOT分析
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in New Mexico, Permian Basin located in West Te …
  • AA PLC:企業の戦略・SWOT・財務情報
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Travelsky Technology Ltd (696):企業の財務・戦略的SWOT分析
    Travelsky Technology Ltd (696) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Southwestern Electric Power Co:発電所・企業SWOT分析
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applica …
  • PT Pertamina (Persero):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Pertamina (Persero) (Pertamina) is a state-owned integrated energy company. It has operations across the energy value chain from upstream to downstream. Its upstream operations include exploration, development and production of oil and natural gas. The company also provides upstream techn …
  • Amscan Holdings, Inc.:企業の戦略・SWOT・財務情報
    Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆